ARCHIVES

IOM Review Of Duke Genomics Trials To Focus On Validation, Scientific Criteria

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

NLST Shows 20.3 Percent Mortality Benefit For CT Vs. X-Ray In Lung Cancer Screening

November 5, 2010

Von Eschenbach says he will continue as NCI director and give both jobs “100 percent.”

September 30, 2005

Folic Acid, Vitamins B6 and 12 Do Not Affect Colorectal Adenoma Risk

October 26, 2012

New Recommendations made For Radiation Protection Standards

August 14, 1987

Clinical Trials Approved By NCI CTEP Last Month

September 30, 2011

Duke Officials Decline To Provide Details Of Probe

July 23, 2010